1998
DOI: 10.1016/s0016-5085(98)83341-6
|View full text |Cite
|
Sign up to set email alerts
|

Subtypes of muscarinic receptors regulating gallbladder cholinergic contractions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

1999
1999
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(11 citation statements)
references
References 17 publications
0
11
0
Order By: Relevance
“…The predominance of muscarinic M 1 autofacilitation was observed when low stimulation frequencies (5 Hz) were used, a situation that coincided with the appearance of small amounts of extracellular adenosine activating inhibitory A 1 receptors (cf. Correia‐de‐Sá et al ., 1996). We have now demonstrated that, besides its physiologically relevant inhibitory role, tonic adenosine A 1 receptors function also prevents the muscarinic M 2 negative feedback mechanism becoming active.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The predominance of muscarinic M 1 autofacilitation was observed when low stimulation frequencies (5 Hz) were used, a situation that coincided with the appearance of small amounts of extracellular adenosine activating inhibitory A 1 receptors (cf. Correia‐de‐Sá et al ., 1996). We have now demonstrated that, besides its physiologically relevant inhibitory role, tonic adenosine A 1 receptors function also prevents the muscarinic M 2 negative feedback mechanism becoming active.…”
Section: Discussionmentioning
confidence: 99%
“…Studies on the functional role of muscarinic modulation on smooth muscle preparations (e.g. urinary bladder, gallbladder) showed that both M 1 ‐facilitatory and M 2 ‐inhibitory receptors can be colocalized in cholinergic nerves (Somogyi et al ., 1994; Parkman et al ., 1999). Using muscarinic antagonists that discriminate between facilitatory M 1 and inhibitory M 2 receptors, respectively, MT‐7 (0.1–1 n m ) or pirenzepine (1–30 n m ) and AF‐DX 116 (0.01–10 µ m ), we could demonstrate that two different subtypes of muscarinic receptors mediate a dual neuromodulatory role at the rat neuromuscular junction.…”
Section: Discussionmentioning
confidence: 99%
“…In airway, the release of ACh from guinea‐pig mesenteric and submucous plexus neurons is inhibited by prejunctional M 1 receptor (Kawashima et al ., 1988; Kilbinger et al ., 1993; Dietrich & Kilbinger, 1995). It is also reported that prejunctional M1 receptors act as excitatory autoreceptors which facilitate the ACh release in rat urinary bladder (Somogyi & de Groat, 1999), guinea‐pig gallbladder (Parkman et al ., 1999) and guinea‐pig ileum (Izzo et al ., 1999). Therefore, muscarinic M1 receptors on different locations may serve distinct physiological functions.…”
Section: Discussionmentioning
confidence: 99%
“…The reported M1 subtype receptor antagonist pirenzepine, the M2 antagonist methoctramine, or the M4 receptor antagonist tropicamide did not have appreciable effects (Table 1). This suggests the cholinergic contractile response of ACh and EFS are primarily mediated through the M3 muscarinic receptor subtype 9 .…”
Section: General Findingsmentioning
confidence: 99%
“…UK 14,304 and citalopram hydrobromide were obtained from Tocris Cookson Inc. (Ellesville, MO, USA). The following muscarinic receptor subtype antagonists were used 9 : pirenzepine dihydrochloride, a M1 receptor antagonist (Sigma Chemical Co.); methoctramine hydrochloride, a M2 receptor antagonist (Research Biochemicals International, Natick, MA, USA); 4‐diphenylacetoxy‐ N ‐methylpiperidine (4‐DAMP) methiodide, a M3 receptor antagonist (Research Biochemicals International); and tropicamide, a reported M4 receptor antagonist (Sigma Chemical Co.).…”
Section: Compoundsmentioning
confidence: 99%